stockrowHarmony Biosciences Holdings, Inc. (HRMY) vs Sarepta Therapeutics, Inc. (SRPT)
- Harmony Biosciences Holdings, Inc. HRMY 33.04 +1.76%
- Sarepta Therapeutics, Inc. SRPT 17.71 +0.80%
Harmony Biosciences Holdings, Inc. and Sarepta Therapeutics, Inc. are both Biotechnology companies. Harmony Biosciences Holdings, Inc. and Sarepta Therapeutics, Inc. are of similar size ($1.9B and $1.9B). Sarepta Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Harmony Biosciences Holdings, Inc. trades at 10.7×. Harmony Biosciences Holdings, Inc. grew revenue faster over the last twelve months: 19.8% against −19.0%. Harmony Biosciences Holdings, Inc. has the higher net margin (18.1% vs −5.86%) and the higher return on invested capital (30.5% vs −2.03%). Across the 19 metrics below, Harmony Biosciences Holdings, Inc. leads on 15 and Sarepta Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | HRMY | SRPT | Biotechnology median |
|---|---|---|---|
| Gross margin | 74.03% | 0.00% | 68.51% |
| Operating margin | 22.17% | (2.50%) | 0.00% |
| Net margin | 18.05% | (5.86%) | 0.00% |
| Free cash flow margin | 32.65% | 9.02% | 0.00% |
| Return on equity | 18.73% | (8.05%) | (51.96%) |
| Return on assets | 13.30% | (3.44%) | (46.06%) |
| Return on invested capital | 30.45% | (2.03%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack